Evaluation of the sympathetic nervous system using heart rate variability and plasma hormones in hypertensive patients treated with cilazapril and atenolol

Cardiology (Switzerland)

Volumn 87, Issue 5, 1996, Pages 402-408

  Campelo, Manuel ^a   Polñnia, Jorge ^a   Serrão, Paula ^a   Cerqueira Gomes, Mario ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Atenolol; Autonomous nervous system; Cilazapril; Heart rate variability; Plasma hormones

Indexed keywords

3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; ANTIHYPERTENSIVE AGENT; ATENOLOL; CILAZAPRIL; NORADRENALIN;

ADRENERGIC SYSTEM; ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART RATE; HUMAN; HYPERTENSION; MALE; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPATHETIC TONE; TREATMENT OUTCOME;

EID: 0029793122     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000177128     Document Type: Article

References (44)

1. Mancia G. Zanchctti A: Neural and psychological factors in hypertension; in Donato L. L'Ab-batc A (cds): Frontiers of Cardiology for the 80’s. London. Academic Press, 1983, pp 17-20.
2. Goldstein DS: Plasma catecholamines and essential hypertension: An analytical review. Hypertension 1983:5:86-89.
3. Malliani A. Pagani M. Lombardi F. Furlan F, Guzzetti S. Cerutti S: Spectral analysis to assess increased sympathetic tone in arterial hypertension. Hypertension 1991:17(4):III36-III42.
4. Esler M. Lambert G. Jennings G: Increased regional sympathetic nervous activity in human hypertension: Causes and consequences. J Hypertens 1990;8(suppl 7):S53-S57.
5. Mancia G: Evaluating sympathetic activity in man. Nutr Mctab Cardiovasc Dis 1994:4:1-2.
6. Esler M. Jennings J. Romer P. Willet I. Dudley F, Hasking G. Anderson W. Lambert G: Assessment of human sympathetic nervous system activity from measurements of noradrenaline turnover. Hypertension 1988:11:3-20.
7. Vallbo A. Hagbarth K. Torebjork H. Wallin B: Somatosensory, proprioceptive and sympathetic activity from peripheral nerves. Physiol Rev 1979;59:919-957.
8. Eiscnhofcr G. Goldstein D. Ropchak T, Nguyen H. Reiser H, Kopin I: Source and physiological significance of plasma 3.4-dihy-droxyphenylglycol and 3-mcthoxy-4-hydroxy-phenvlglycol. J Auton Nerv Syst 1988:24:1-14.
9. Akselrod S. Gordon D. Hubei F. Shannon D. Berger A. Cohen R: Power spectrum analysis of heart rate variability: A quantitative probe of beat-to-beat cardiovascular control. Science 1981;213:220-222.
10. Malik M. Camm A: Heart rate variability and clinical cardiology. Br Heart J 1994:71:3-6.
11. Ahmed M. Radish A. Parker M. Goldbcrger J: Effect of physiologic adrenergic stimulation on heart rate variability. J Am Coll Cardiol 1994: 24:1082-1090.
12. Robayashi M. Musha T: Fluctuation of heart beat period. IEEE Trans Biomcd Eng 1982; BME-9(6):456-457.
13. Pagani M, Lombardi F. Guzzetti S. Rinioldi O. Furlan F, Pizzinelli P, Sandrone G. Malfatto G. Dell'Orto S. Piccaluga E. Turiel M. Baselli G. Cerutti S. Malliani A: Power spectral analysis of heart rate and arterial pressure variability as a marker of sympathovagal interactions in man and conscious dog. Circ Res 1986;59:178-193.
14. Malliani A. Pagani M. Lombardi F. Cerutti S: Cardiovascular neural regulation explored in the frequency domain. Circulation 1991:84: 482-492.
15. Furlan F. Guzzetti S, Crivellaro W. Dassi S, Tinelli M. Baselli G, Cerutti S, Lombardi F. Pagani M. Malliani A: Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects. Circulation 1990:81:537-547.
16. Pomeranz B. Macaulay R, Caudill M. Rutz T. Adam D. Gordon R. Rilbom R, Barger A, Shannon D. Cohen R. Benson H: Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 1985:248: HI51-I53.
17. Cook J, Bigger J. Rleigcr R, Flciss J. Steinman R. Rolnitzky L: Effect of atenolol and diltiazem on heart period variability in normal persons. J Am Coll Cardiol 1991; 17:480-484.
18. Rleigcr R. Bigger J. Bosncr M. Chung M. Cook J. Rolnitzky L, Steinman R. Fleiss J: Stability over time of variables measuring heart rate variability in normal subjects. Am J Cardiol 1991:68:626-630.
19. Appel M. Berger R. Saul J, Smith J. Cohen R: Beat-to-beat variability in cardiovascular variables: Noise or music? J Am Coll Cardiol 1989; 14:1139-1148.
20. Yamamoto Y. Hugson R. Peterson J: Autonomic control of heart rate during exercise studied by heart rate variability spectral analysis. J Appl Physiol 1991:71:1136-1142.
21. Brcuer A, Skyschallv A. Schulz R. Martin C. Whcr M. Heusch G: Heart rate variability and circulating catecholamine concentrations during steady-state exercise in healthy controls. Br Heart J 1993:70:144-149.
22. Saul J. Rea R. Berger R. Eckberg D. Cohen R: Spectral analysis of peroneal nerve sympathetic activity and heart rate in man. IEEE Trans Biomed Eng 1987;423-426.
23. Saul J. Yutaka A. Berger R. Lilly S. Colluci W, Cohen R: Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis. Am J Cardiol 1988:61:1292-1299.
24. Adamopoulos S. Piepoli M. McAnce A. Bcr-nardi L, Rocadaelli A. Ormcrod O. Forfar C, Sleight P, Coats A: Comparison of different methods for assessing sympathovagal balance in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1992:70: 1576-1582.
25. Edwards C, Paddlefield P: Angiotensin converting-enzyme inhibitors: Past, present and bright future. Lancet 1985;i:30-34.
26. Campbell B, Sturani A, Reid J: Evidence of parasympathetic activity of the angiotensin converting enzyme inhibitor caplopril. in man. Clin Sci 1985:68:49-56.
27. Coker R. Rozicl! A. Oliver C, Smith S: Does the sympathetic nervous system influence sinus arrhythmia in man? Evidence from combined autonomic blockade. J Physiol 1984:356:459-464.
28. Ahmad A, Harness J. Mcams A: Respiratory control of heart rate. Eur J Appl Physiol 1982; 50:95-104.
29. Branco D. Osswald W: High-pressure liquid chromatography of plasma cathccols. an advance in the diagnosis of pheochromocytoma. Rev Port Cardiol 1983;2(6):551-555.
30. Soares-da-Silva P: Preferential decarboxylation of /.-theo-3.4-dihydroxyphenylscrinc in rat renal tissues. Gen Pharmacol 1993;24(1):75-81.
31. Goldzer R. Lilly L. Solomon H: Prevalence of cough during angiotensin converting enzyme inhibitor therapy. Am J Med 1988:85(6):887.
32. Zanchctti A. Fitzpatrick M. Julius S: Hemodynamic effects of angiotensin converting enzyme inhibitors in essential hypertension: A review. J Cardiovasc Pharmacol 1985:7:535-539.
33. Sturani A, Chiarini C. Degli E, Santoro A. Zuc-cala A, Zucchelli P: Heart rate control in hypertensive patients treated with captopril. Br J Clin Pharmacol 1982:14:849-855.
34. Clcland J. Semple P. Hodsman P. Ball S. Ford I. Dargie H: Angiotensin II levels, hemodynamics and sympathoadrenal function after low-dose caplopril in heart failure. Am J Med 1984:77:880-886.
35. Zimmerman B. Svbertz E. Wong P: Interaction between sympathetic and renin-angiotensin systems. J Hypertens 1984;2:581-587.
36. Lee W. Isrnay M. Lumbers E: Mechanisms by which angiotensin II affects the heart rateofthc conscious sheep. Circ Res 1980:47:286-292.
37. Ajayi A, Campbell B, Howie C. Reid L: Acute and chronic effects of the converting enzyme inhibitors cnalapril and lisinopril on reflex control of heart rate in normotensive man. J Hypertens 1985:3:47-53.
38. Bosncr M, Raufman E, Stein P. Rleigcr R. Bigger J. Rolnitzky L. Fleiss J: The effect of cnalapril and digoxin on heart period variability in normal subjects. Circulation 1991;84(suppl Iss II): 616.
39. Quadri R. Papotti G, Grotta A. Maulc S. Za-nonc M. Valcntini M. Fonzo D, Chiandussi L: Acc-inibitori e attivita vagalc: Effctto di captopril c lisinopril su alcuni rcflcssi cardiovasco-lari. Ann Ital Med int 1992:7:148-152.
40. Morioka S. Simon G. Cohn J: Cardiac and hormonal effects of enalapril in hypertension. Clin Pharmacol Ther 1983:34:583-589.
41. Polonia J. Monteiro A. Esteves A. Cunha M. Santos M. Coutinho J, Coclho J, Brandao F. Cerqueira-Gomcs M: Influence of sublingual captopril on plasma catecholamine levels during hypertensive emergencies and cold immersion. Am J Med 1988;84(suppl 3A): 148-151.
42. Becker R. Struthers A. Brown M: Effect of captopril on changes in plasma noradrenaline induced by sodium nitroprusside. Br J Clin Pharmacol 1986:22:409-413.
43. Clcmcnti W, Durst N, McNav J, Reelon T: Captopril modifies the hemodynamic and neuroendocrine responses to sodium nitroprusside in hypertensive patients. Hypertension 1986:8: 229-237.
44. Ewing D. Ncilson J. Travis P: New method for assessing cardiac parasympathetic activity using 24-hour electrocardiograms. Br Heart J 1984;52:396-402.